Ryan P Merkow1, Karl Y Bilimoria, Karen L Sherman, Martin D McCarter, Howard S Gordon, David J Bentrem. 1. Feinberg School of Medicine, Northwestern University; Jesse Brown Veterans Affairs (VA) Medical Center; VA Center for Management of Complex Chronic Care; University of Illinois at Chicago College of Medicine, Chicago, IL; University of Colorado Denver, Anschutz Medical Campus, Aurora; and Denver VA Medical Center, Denver, CO.
Abstract
PURPOSE: Timeliness of cancer treatment is an important aspect of health care quality. Veterans Affairs Medical Centers (VAMCs) are expected to treat a growing number of patients with cancer. Our objectives were to examine treatment times from diagnosis to first-course therapy for patients with colon and rectal cancers and assess factors associated with prolonged wait times. METHODS: From the VA Central Cancer Registry, patients who underwent colon or rectal resection for cancer from 1998 to 2008 were identified. Time from diagnosis to definitive cancer-directed therapy was measured, and multivariable regression methods were used to determine predictors of prolonged wait times for colon (≥ 45 days) and rectal (≥ 60 days) cancers. RESULTS: From 124 VAMCs, 14,097 patients underwent colectomy, and 3,390 underwent rectal resection for cancer. For colon cancer, the median time to treatment increased by 68% over time (P < .001). From 2007 to 2008, the median time to colectomy was 32 days. Predictors of prolonged wait times included age ≥ 55 years (v < 55 years), time period (2007 to 2008 v 1998 to 2000), black race (v white), marriage status (married v unmarried), high-volume center status (v low volume), and treatment at a different hospital (v same hospital as initial diagnosis; all P < .05). For rectal cancer, the overall median time to first-course treatment increased by 74% (P < .001). From 2007 to 2008, the median time to proctectomy was 47 days. Similar predictors of prolonged wait times were identified for rectal cancer. CONCLUSION: Time to first treatment has increased for patients with colon and rectal cancers at VAMCs. Patient, tumor, and hospital factors are associated with prolonged time to treatment.
PURPOSE:Timeliness of cancer treatment is an important aspect of health care quality. Veterans Affairs Medical Centers (VAMCs) are expected to treat a growing number of patients with cancer. Our objectives were to examine treatment times from diagnosis to first-course therapy for patients with colon and rectal cancers and assess factors associated with prolonged wait times. METHODS: From the VA Central Cancer Registry, patients who underwent colon or rectal resection for cancer from 1998 to 2008 were identified. Time from diagnosis to definitive cancer-directed therapy was measured, and multivariable regression methods were used to determine predictors of prolonged wait times for colon (≥ 45 days) and rectal (≥ 60 days) cancers. RESULTS: From 124 VAMCs, 14,097 patients underwent colectomy, and 3,390 underwent rectal resection for cancer. For colon cancer, the median time to treatment increased by 68% over time (P < .001). From 2007 to 2008, the median time to colectomy was 32 days. Predictors of prolonged wait times included age ≥ 55 years (v < 55 years), time period (2007 to 2008 v 1998 to 2000), black race (v white), marriage status (married v unmarried), high-volume center status (v low volume), and treatment at a different hospital (v same hospital as initial diagnosis; all P < .05). For rectal cancer, the overall median time to first-course treatment increased by 74% (P < .001). From 2007 to 2008, the median time to proctectomy was 47 days. Similar predictors of prolonged wait times were identified for rectal cancer. CONCLUSION: Time to first treatment has increased for patients with colon and rectal cancers at VAMCs. Patient, tumor, and hospital factors are associated with prolonged time to treatment.
Authors: Marko Simunovic; Marc-Erick Thériault; Lawrence Paszat; Angela Coates; Timothy Whelan; Eric Holowaty; Mark Levine Journal: Can J Surg Date: 2005-04 Impact factor: 2.089
Authors: Sunny Wang; Melisa L Wong; Nathan Hamilton; J Ben Davoren; Thierry M Jahan; Louise C Walter Journal: J Clin Oncol Date: 2012-03-26 Impact factor: 44.544
Authors: Karin Gwyn; Melissa L Bondy; Deborah S Cohen; Mary Jo Lund; Jonathan M Liff; Elaine W Flagg; Louise A Brinton; J William Eley; Ralph J Coates Journal: Cancer Date: 2004-04-15 Impact factor: 6.860
Authors: Eric E Seiber; Fabian Camacho; Muhammad Fazal Zeeshan; Teresa T Kern; Steven T Fleming Journal: J Rural Health Date: 2015-05-29 Impact factor: 4.333
Authors: Leah L Zullig; Kellie J Sims; Rebecca McNeil; Christina D Williams; George L Jackson; Dawn Provenzale; Michael J Kelley Journal: Mil Med Date: 2017-07 Impact factor: 1.437
Authors: Rebecca L Gunter; Skyler Chouinard; Sara Fernandes-Taylor; Jason T Wiseman; Sam Clarkson; Kyla Bennett; Caprice C Greenberg; K Craig Kent Journal: J Am Coll Surg Date: 2016-02-13 Impact factor: 6.113
Authors: Munir Ahmad Abu-Helalah; Hussam Ahmad Alshraideh; Moh'd Da'na; Mo'tasem Al-Hanaqtah; Anas Abuseif; Kamal Arqoob; Abdelrahman Ajaj Journal: J Gastrointest Cancer Date: 2016-03
Authors: Gretchen C Edwards; Adriana C Gamboa; Michael P Feng; Roberta L Muldoon; Michael B Hopkins; Sherif Abdel-Misih; Glen C Balch; Jennifer Holder-Murray; Maryam Mohammed; Scott E Regenbogen; Matthew L Silviera; Alexander T Hawkins Journal: Surgery Date: 2021-09-24 Impact factor: 4.348
Authors: Roxanne J Wadia; Xiaopan Yao; Yanhong Deng; Jia Li; Steven Maron; Donna Connery; Handan Gunduz-Bruce; Michal G Rose Journal: Cancer Med Date: 2015-06-09 Impact factor: 4.452
Authors: Jesse T Davidson; Jonathan S Abelson; Sean C Glasgow; Steven R Hunt; Matthew G Mutch; Paul E Wise; Matthew L Silviera; Radhika K Smith Journal: Am J Surg Date: 2020-12-08 Impact factor: 2.565